Gabrail Cancer Center Research, LLC

Canton, Ohio 44718

1 studies enrolling now · 8 studies all time

What they study most

Advanced Melanoma, Bladder Urothelial Carcinoma, Breast Cancer, Carcinoma Non-small Cell Lung Cancer Stage IIIA, Carcinoma Non-small Cell Lung Cancer Stage IIIB, Carcinoma Non-small Cell Lung Cancer Stage IV, Carcinoma, Non-Small- Cell Lung, Carcinoma, Transitional Cell, Cholangiocarcinoma, Colorectal Cancer, Diffuse Large B-cell Lymphoma (DLBCL), Esophageal Adenocarcinoma

Studies at this site

• Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma. — Recruiting now
• Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors — Running, not enrolling
• A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer — Stopped early
• A Study of SEA-CD40 Given With Other Drugs in Cancers — Completed
• SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma. — Stopped early
• A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors — Stopped early
• A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies — Completed
• Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy — Completed